IL164250A0 - Chimeric pancreas - Google Patents
Chimeric pancreasInfo
- Publication number
- IL164250A0 IL164250A0 IL16425003A IL16425003A IL164250A0 IL 164250 A0 IL164250 A0 IL 164250A0 IL 16425003 A IL16425003 A IL 16425003A IL 16425003 A IL16425003 A IL 16425003A IL 164250 A0 IL164250 A0 IL 164250A0
- Authority
- IL
- Israel
- Prior art keywords
- recipient
- mammalian
- pancreatic
- tissue
- pancreatic tissue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2806—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36718102P | 2002-03-25 | 2002-03-25 | |
PCT/US2003/009091 WO2003083064A2 (fr) | 2002-03-25 | 2003-03-24 | Pancreas chimerique |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164250A0 true IL164250A0 (en) | 2005-12-18 |
Family
ID=28675331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16425003A IL164250A0 (en) | 2002-03-25 | 2003-03-24 | Chimeric pancreas |
Country Status (16)
Country | Link |
---|---|
US (2) | US7384630B2 (fr) |
EP (1) | EP1487967B1 (fr) |
JP (1) | JP2005521497A (fr) |
KR (1) | KR20040099350A (fr) |
CN (1) | CN1643133A (fr) |
AT (1) | ATE484576T1 (fr) |
AU (1) | AU2003259298B2 (fr) |
BR (1) | BR0308718A (fr) |
CA (1) | CA2477538C (fr) |
DE (1) | DE60334534D1 (fr) |
EA (1) | EA200401244A1 (fr) |
IL (1) | IL164250A0 (fr) |
MX (1) | MXPA04009411A (fr) |
NO (1) | NO20044540L (fr) |
WO (1) | WO2003083064A2 (fr) |
ZA (1) | ZA200406983B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL165425A0 (en) * | 2004-11-28 | 2006-01-15 | Yeda Res & Dev | Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
US20090155229A1 (en) * | 2004-12-06 | 2009-06-18 | Avner Yayon | Chondrocyte-based implant for the delivery of therapeutic agents |
WO2007023491A2 (fr) * | 2005-08-24 | 2007-03-01 | Yeda Research And Development Co. Ltd. | Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique |
EP1926459B1 (fr) | 2005-09-19 | 2015-01-07 | Histogenics Corporation | Matrice support de cellules dont la densite des pores et la porosite sont definies specifiquement de maniere uniforme verticalement et organisees de maniere non aleatoire, et procede de preparation de celle-ci |
US8685107B2 (en) | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
US20090054984A1 (en) | 2007-08-20 | 2009-02-26 | Histogenics Corporation | Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects |
US8709400B2 (en) * | 2009-07-27 | 2014-04-29 | Washington University | Inducement of organogenetic tolerance for pancreatic xenotransplant |
CN102858380B (zh) * | 2009-08-02 | 2016-03-23 | 学校法人东京女子医科大学 | 胰岛细胞片、制造方法及其利用方法 |
US9420770B2 (en) | 2009-12-01 | 2016-08-23 | Indiana University Research & Technology Corporation | Methods of modulating thrombocytopenia and modified transgenic pigs |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804178A (en) * | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
EP0552336A1 (fr) * | 1991-08-02 | 1993-07-28 | Systemix, Inc. | Implants primordiaux dans des hotes immunodeficients |
EP0642784B1 (fr) * | 1993-09-07 | 1999-05-19 | Gerhard Dr. Gergely | Mélange effervescent contenant des sels alcalins ou lysinates de principes actifs acides insolubles ou à faible solubilité |
US5560911A (en) * | 1993-10-12 | 1996-10-01 | Oklahoma Medical Research Foundation | Method of inhibiting acute complement mediated cytotoxicity with anti-idiotypic antibodies |
US5629194A (en) * | 1994-10-21 | 1997-05-13 | Diacrin, Inc. | Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
EP1257282A4 (fr) | 1999-12-06 | 2003-05-02 | Gen Hospital Corp | Cellules souches pancreatiques et leur utilisation en transplantation |
AU2001274860A1 (en) * | 2000-05-18 | 2001-11-26 | Biotransplant, Inc. | Process for reducing antibody response against xenografts |
US20030031652A1 (en) * | 2001-04-16 | 2003-02-13 | Bernhard Hering | Systems and methods for inducing mixed chimerism |
-
2003
- 2003-03-24 DE DE60334534T patent/DE60334534D1/de not_active Expired - Lifetime
- 2003-03-24 WO PCT/US2003/009091 patent/WO2003083064A2/fr active Application Filing
- 2003-03-24 AU AU2003259298A patent/AU2003259298B2/en not_active Ceased
- 2003-03-24 US US10/395,552 patent/US7384630B2/en not_active Expired - Fee Related
- 2003-03-24 AT AT03745590T patent/ATE484576T1/de not_active IP Right Cessation
- 2003-03-24 IL IL16425003A patent/IL164250A0/xx unknown
- 2003-03-24 EP EP03745590A patent/EP1487967B1/fr not_active Expired - Lifetime
- 2003-03-24 MX MXPA04009411A patent/MXPA04009411A/es unknown
- 2003-03-24 JP JP2003580500A patent/JP2005521497A/ja not_active Withdrawn
- 2003-03-24 KR KR10-2004-7014872A patent/KR20040099350A/ko not_active Application Discontinuation
- 2003-03-24 CN CNA038066998A patent/CN1643133A/zh active Pending
- 2003-03-24 BR BR0308718-2A patent/BR0308718A/pt not_active IP Right Cessation
- 2003-03-24 EA EA200401244A patent/EA200401244A1/ru unknown
- 2003-03-24 CA CA002477538A patent/CA2477538C/fr not_active Expired - Fee Related
-
2004
- 2004-09-01 ZA ZA200406983A patent/ZA200406983B/en unknown
- 2004-10-22 NO NO20044540A patent/NO20044540L/no not_active Application Discontinuation
-
2008
- 2008-05-09 US US12/118,430 patent/US20080318202A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030198628A1 (en) | 2003-10-23 |
ZA200406983B (en) | 2005-09-22 |
CN1643133A (zh) | 2005-07-20 |
US20080318202A1 (en) | 2008-12-25 |
KR20040099350A (ko) | 2004-11-26 |
CA2477538C (fr) | 2008-01-29 |
WO2003083064A2 (fr) | 2003-10-09 |
DE60334534D1 (de) | 2010-11-25 |
US7384630B2 (en) | 2008-06-10 |
BR0308718A (pt) | 2005-01-04 |
WO2003083064A3 (fr) | 2004-03-25 |
MXPA04009411A (es) | 2005-01-25 |
EP1487967A2 (fr) | 2004-12-22 |
EP1487967B1 (fr) | 2010-10-13 |
CA2477538A1 (fr) | 2003-10-09 |
EP1487967A4 (fr) | 2005-05-11 |
AU2003259298A1 (en) | 2003-10-13 |
ATE484576T1 (de) | 2010-10-15 |
EA200401244A1 (ru) | 2005-02-24 |
NO20044540L (no) | 2004-10-22 |
JP2005521497A (ja) | 2005-07-21 |
AU2003259298B2 (en) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009014273A (es) | Metodos y composiciones para expansion e implantacion optimizadas de celulas madre mesenquimales. | |
TW200503794A (en) | Treatment of tissue with undifferentiated mesenchymal cells | |
IL164250A0 (en) | Chimeric pancreas | |
WO2009050742A8 (fr) | Utilisation de microvésicules (mvs) pour préparer un médicament ayant une activité d'adjuvant sur la transplantation de cellules endothéliales, en particulier dans le traitement du diabète par une transplantation d'îlots pancréatiques, et procédé associé | |
DE69937888D1 (de) | Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen | |
WO2010022395A3 (fr) | Procédés de reprogrammation de cellules | |
WO2006107850A3 (fr) | Procede de prevention du rejet d'un tissu transplante | |
WO2003059276A3 (fr) | Nouvelles cellules souches multipotentes d'origine mammalienne, methodes de preparation et methodes d'administration desdites cellules | |
WO2005120576A3 (fr) | Composition et methode permettant d'ameliorer la survie des cellules des ilots de langerhans | |
AU2003208567A1 (en) | Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells | |
WO2005081870A3 (fr) | Reparation de disque intervertebral, methodes et dispositifs associes | |
EP1248640A4 (fr) | Preparation et xenotransplantation d'ilots de porc | |
IL145795A (en) | Mutant human cd80 and compositions for and methods of making and using the same | |
WO2001068828A3 (fr) | Compositions et methodes destinees a l'expression regulee d'une proteine dans l'intestin | |
MX2008000787A (es) | Metodo facil para trasplantar condrocito inyectable para trasplante autologo de condrocitos. | |
GB2397825B (en) | Method of producing human beta cell lines | |
WO2006017567A3 (fr) | Adaptation de cardiomyocytes derives de cellules souches pour transplantation | |
WO2009062260A8 (fr) | Thérapie pour la sclérose en plaques | |
WO2011059733A3 (fr) | Utilisation d'acide lipoïque dans une transplantation de cellule | |
WO2004052305A3 (fr) | Lactoferrine utilisee en tant qu'agent de prevention du rejet d'organes transplantes et de la reaction de greffe contre hote | |
Sackett et al. | Human embryonic stem cells (hESC) as a source of insulin-producing cells | |
WO2005059095A3 (fr) | Dilatation et differenciation de cellules des ilots pancreatiques | |
WO2006079107A3 (fr) | Compositions pour transplantation et procedes de traitement des diabetes | |
WO2004113512A3 (fr) | Methode de production de cellules beta d'ilots de langerhans a partir de cellules exocrines du pancreas | |
DK1664307T3 (da) | Ny endospermspecifik plantepromotor til afgröder |